Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. University of Siena, Siena, Italy



Survival: 10.7 months
   
Toxicity Grade: 3
   
Treatments: Chemotherapy
   
Drugs:
Country: Italy
   
City/State/Province: Siena
   
Hospital: University of Siena
   
Journal: Link
   
Date: 3/2015

Description:
Patients:
This study involved 26 advanced, metastatic castration-resistant prostate cancer patients who had been previously treated with docetaxel and abiraterone acetate. The median patient age was 72 years.

Treatment:
Patients received chemotherapy with docetaxel and epirubicin.

Toxicities:
The most severe toxicities were of grade 3 and included neutropenia, anemia, and fatigue.

Results:
The median overall survival was 10.7 months.

Correspondence: Dr. Roberto Petrioli; email: r.petrioli@ao-siena.toscana.it

E-mail to a Friend Email Physician More Information